miércoles, 6 de marzo de 2024

Semaglutide reduces severity of common liver disease in people with HIV NIH-funded findings inform interdisciplinary care approach across the lifespan.

https://www.nih.gov/news-events/news-releases/semaglutide-reduces-severity-common-liver-disease-people-hiv

No hay comentarios:

Publicar un comentario